Press "Enter" to skip to content

Merck KGaA-Pfizer to end late-stage ovarian cancer treatment study

Merck KGaA and Pfizer Inc said on Friday they were ending a late-stage study for their drug to treat a form of ovarian cancer in previously untreated patients.

Original source: http://feeds.reuters.com/~r/reuters/INhealth/~3/uCIl-R2TTAA/merck-kgaa-pfizer-to-end-late-stage-ovarian-cancer-treatment-study-idINKCN1OK25I

Also Read:   Astrazeneca gets marketing authorisation to use anti-diabetes drug for kidney disease